U.S. Physical Therapy (NYSE:USPH) Releases Earnings Results, Misses Expectations By $0.04 EPS

U.S. Physical Therapy (NYSE:USPH) released its earnings results on Wednesday. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04), Zacks reports. The business had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%.

U.S. Physical Therapy Stock Down 8.3 %

NYSE USPH traded down $7.28 during trading hours on Thursday, reaching $80.44. 86,083 shares of the company’s stock traded hands, compared to its average volume of 91,986. The firm has a market cap of $1.21 billion, a PE ratio of 85.49, a PEG ratio of 3.54 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The firm has a 50-day simple moving average of $88.59 and a 200 day simple moving average of $87.70.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on USPH shares. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Barrington Research reaffirmed an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and an average price target of $114.00.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.70% of the stock is owned by company insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.